Aug 13, 2020
ViaCyte Appoints Dr. Manasi Sinha Jaiman as Vice President, Clinical Development
May 28, 2020
ViaCyte to Present at the Jefferies Virtual Healthcare Conference
May 26, 2020
ViaCyte Announces $27 Million Financing to Advance Next Generation Cell Therapies for Diabetes
Dec 10, 2019
GIOSTAR in Process of US FDA Approval for Type 2 Diabetes Clinical Trial
Nov 19, 2019
Kadimastem Announces Successful Preclinical Results of Its Cell Therapy Treatment for Insulin-dependent Diabetes
Sep 20, 2019
SymbioCellTech Announces Publication in PLOS ONE, Demonstrating 'Neo-Islets' as Significant Advance in Stem Cell Therapy for Type 1 Diabetes
Jul 16, 2019
Human Pancreas on a Chip Opens New Possibilities for Studying Disease
Jun 27, 2019
ViaCyte Appoints Sandra E. Poole to Board of Directors
Jun 19, 2019
SERAXIS Inc. inks Research Collaborative Agreement with North Carolina Research Hospital
Feb 19, 2019
Diabetes Research Institute Scientists Engineer 'Suicide Genes' to Safely Grow Insulin-Producing Beta Cells from Stem Cells
Jan 29, 2019
ViaCyte Announces New Board Members
Jan 21, 2019
Center for Beta Cell Therapy in Diabetes and ViaCyte Announce Start of European Clinical Trial of Human Stem Cell-derived Implants in Type 1 Diabetes Patients
Jan 04, 2019
ViaCyte Provides Update on Patent Portfolio in Stem Cell-Derived Cell Replacement Therapies for Type 1 Diabetes and Other Indications
Sep 05, 2018
SERAXIS Inc. announces novel method and cell line that generate highly pure populations of insulin-producing cells capable of reversing diabetes in rodents.
Aug 22, 2018
Koligo introduces KYSLECEL(TM) autologous cell therapy product
May 08, 2018
Tissue Engineered Human Pancreas Cells Successfully Treat Diabetic Mice
Jan 05, 2018
ViaCyte Announces First Patients Implanted in Cohort 2 with Potentially Efficacious Dose of PEC-Direct Islet Cell Replacement Therapy
Dec 06, 2017
ViaCyte Selected as a Winner of CONNECT's 30th Annual Most Innovative New Product Awards
Sep 21, 2017
ViaCyte Selected as a Finalist for CONNECT's 30th Annual Most Innovative New Product Awards
Aug 01, 2017
ViaCyte Announces First Patients Implanted with PEC-Direct Islet Cell Replacement Therapy in International Clinical Trial